Cargando…
Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
There is a strong association between BRCA1 mutation carrier status and estrogen receptor-negative breast cancer. This has led to the idea that estrogen receptor-positive breast cancers in BRCA1 mutation carriers may be incidental or sporadic in nature and not as a direct result of BRCA1 dysfunction...
Autores principales: | Lakhani, Sunil R, Khanna, Kum Kum, Chenevix-Trench, Georgia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879558/ https://www.ncbi.nlm.nih.gov/pubmed/20346095 http://dx.doi.org/10.1186/bcr2483 |
Ejemplares similares
-
High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations
por: Johnston, Rebecca L., et al.
Publicado: (2016) -
An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
por: Chenevix-Trench, Georgia, et al.
Publicado: (2007) -
No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer
por: Spurdle, Amanda B, et al.
Publicado: (2002) -
Rad51 supports triple negative breast cancer metastasis
por: Wiegmans, Adrian P, et al.
Publicado: (2014) -
No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer
por: Campbell, Ian G, et al.
Publicado: (2004)